UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Stroke - prevention & control | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Cardiovascular Diseases - mortality | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptides - analogs & derivatives | Diabetes Mellitus, Type 2 - complications | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Evidence-based medicine | Risk factors | Incidence | Randomization | Older people | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Albuminuria - prevention & control | Creatinine - urine | Glomerular Filtration Rate - drug effects | Female | Aged | Glucagon-Like Peptides - therapeutic use | Immunoglobulin Fc Fragments - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Glucagon-Like Peptides - analogs & derivatives | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Evidence-based medicine | Risk factors | Incidence | Randomization | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Cardiology, ISSN 0008-6312, 1992, Volume 80, Issue 5-6, pp. 448 - 450
Journal Article
Cardiology, ISSN 0008-6312, 1992, Volume 80, Issue 5-6, pp. 445 - 447
Journal Article
Cardiology, ISSN 0008-6312, 1992, Volume 80, Issue 5-6, pp. I - VI
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.